SCK
Shengqi Capital (Hong Kong) Ltd. Portfolio
Invests via Shengqi Capital (Hong Kong) Ltd. | Managed by Lau Ka Chun
Invests via Shengqi Capital (Hong Kong) Ltd.
Managed by Lau Ka Chun
Automatically Tracked
Company Profile
Targets Greater China private equity opportunities across growth-stage technology, consumer and healthcare companies, deploying equity and structured capital through direct investments and co-investments for institutional and family-office clients. The firm leverages Hong Kong as a regional base to source cross-border deal flow between mainland China and global investors, emphasizing operational support, follow-on funding and exit preparation via strategic trade buyers or IPOs.
Targets Greater China private equity opportunities across growth-stage technology, consumer and healthcare companies, deploying equity and structured capital through direct investments and co-investments for institutional and family-office clients. The firm leverages Hong Kong as a regional base to source cross-border deal flow between mainland China and global investors, emphasizing operational support, follow-on funding and exit preparation via strategic trade buyers or IPOs.
Investment Philosophy & Strategy
Operates as a Greater China growth private equity allocator that prioritizes technology, consumer and healthcare leaders with clear paths to scalable revenue and cross-border expansion. Capital deployment blends direct equity, structured instruments and co‑investments to balance upside and downside protection, with staged follow‑on reserves for operational scale. Underwriting emphasizes revenue growth, unit economics, founder alignment and exit-readiness via trade sales or Hong Kong/China IPOs. Typical horizon is 3–7 years with active governance and operational support.
Operates as a Greater China growth private equity allocator that prioritizes technology, consumer and healthcare leaders with clear paths to scalable revenue and cross-border expansion. Capital deployment blends direct equity, structured instruments and co‑investments to balance upside and downside protection, with staged follow‑on reserves for operational scale. Underwriting emphasizes revenue growth, unit economics, founder alignment and exit-readiness via trade sales or Hong Kong/China IPOs. Typical horizon is 3–7 years with active governance and operational support.
Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
5.36%
Gain
Monthly
0.24%
Yearly
2.96%
Drawdown
47.92%
$52,927.32
Equity
Holdings
$52,927.32
Investment
$45,574.5
$26.72M
Profit -$2,680.86
Realized
$26.71M
Unrealized
$7,352.82
Dividends
$370,871.98
Goals
Avg. 100% completed goals
Yearly
Gain > 5% 2026
Yearly
Gain < 20% 2026
Today
Compared To Yesterday
Gain
0%
Profit
-$2,680.86
Win %
50%
This Week
Compared To Last Week
Gain
-3%
Profit
-$1,634.38
Win %
50%
This Month
Compared to last month
Gain
-1.59%
Profit
-$854.38
Win %
50%
This Year
Compared to last year
Gain
54.3%
Profit
$17,358.92
Win %
50%
Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 17 | Longs Won 5/17 29% | Profit Factor 3.5 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $5.39M |
| Average Win $6.43M | Best Trade (Dec 31) $16.69M | Sharpe Ratio -7.73 |
| Average Loss -$765,043.97 | Worst Trade (Sep 29) -$5.93M | Z-Score 1.49 (86.46%) |
| Commissions $0 | Avg. Trade Length 6m 2w 1d | Expectancy $1.57M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | ∞ | ∞ | ∞ | ∞ | ∞ | ∞ | ∞ | ∞ | ∞ | ∞ |
Hover over the desired column for a detailed explanation.
Returns
Overall, MonthlyNo Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
